Make prescribing decisions with our comparative charts and treatment algorithms.
Quickly and accurately perform clinical calculations.
Download or print easy-to-read disease leaflets for your patients.
Get valuable insight on select drug products and medically-relevant topics, courtesy of the pharmaceutical industry.
Hospira announced a voluntary nationwide recall of one lot of 0.25% Marcaine (bupivacaine HCl) injection, single-dose 10mL vials due to discolored solution with visible particles embedded in the glass as well as the presence of discolored solution.
The FDA Anesthetic and Analgesic Drug Products Advisory Committee will be meeting to evaluate QRxPharma's revised New Drug Application (NDA) for Moxduo (morphine sulfate and oxycodone hydrochloride) for the management of moderate to severe acute pain.
Hospira has initiated a voluntary recall of one lot of Lidocaine HCl injection 1%, 10mg/mL, single-dose 30mL vials due to an orange and black particulate found within the solution and embedded within the glass vial.
This program will discuss the causes of chronic pain as well as pharmacological options for ...
This course offers practicing physicians, mid-level practitioners, nurses and other allied health professionals a comprehensive ...
To minimize the risk of abuse and addiction, evidence-based prescribing practices must be used when ...